首页 > 最新文献

Trends in Cardiovascular Medicine最新文献

英文 中文
Cardio Obstetrics: bridging heart and pregnancy health. 心血管产科:连接心脏和孕期健康的桥梁。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-19 DOI: 10.1016/j.tcm.2024.10.005
Rachel L Goldberg, Sindhu Prabakaran, Nandita S Scott

Cardiovascular disease remains a major contributor to maternal morbidity and mortality in the United States. Cardio Obstetrics is a nascent field for which most cardiovascular clinicians have not received any formal training. This has resulted in knowledge and care gaps. In this review we provide principles to guide the care for the evaluation and management of pregnancy capable individuals, which should be considered the standard knowledge for all clinicians.

在美国,心血管疾病仍然是孕产妇发病和死亡的主要原因。心血管产科是一个新兴领域,大多数心血管临床医生都没有接受过任何正规培训。这就造成了知识和护理方面的差距。在这篇综述中,我们提供了指导评估和管理有能力怀孕者的护理原则,这些原则应被视为所有临床医生的标准知识。
{"title":"Cardio Obstetrics: bridging heart and pregnancy health.","authors":"Rachel L Goldberg, Sindhu Prabakaran, Nandita S Scott","doi":"10.1016/j.tcm.2024.10.005","DOIUrl":"https://doi.org/10.1016/j.tcm.2024.10.005","url":null,"abstract":"<p><p>Cardiovascular disease remains a major contributor to maternal morbidity and mortality in the United States. Cardio Obstetrics is a nascent field for which most cardiovascular clinicians have not received any formal training. This has resulted in knowledge and care gaps. In this review we provide principles to guide the care for the evaluation and management of pregnancy capable individuals, which should be considered the standard knowledge for all clinicians.</p>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unexplained Sudden Cardiac Arrest and Sudden Cardiac Death in the Young: What is Killing These Young People When Nothing is Found? 年轻人不明原因的心脏骤停和心脏性猝死:在没有任何发现的情况下,是什么夺走了这些年轻人的生命?
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-19 DOI: 10.1016/j.tcm.2024.11.002
Andrew S Tseng, Mayank Sardana, John R Giudicessi, Michael J Ackerman

Unexplained sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in the young remains a critical issue for clinicians, researchers, patients and their family members. In this review, we explore the current status of SCA and SCD evaluation in the young, including recent monogenic and polygenic disease discoveries, advancements in cardiac imaging and our growing understanding of the role of the Purkinje system in triggering life threatening and even fatal ventricular arrhythmias. Yet, despite these advancements, over a third of SCA and SCD among individuals with seemingly structurally normal hearts remain unexplained. We explore the future role of artificial intelligence, novel biomarkers, multimodality cardiac imaging, genetic discoveries, as well as wearable devices and sensors in closing this current gap. With the overarching framework provided in this review, we envision a future in which collaboration among patients, clinicians, researchers, innovators, and policy makers culminates in our ability to diagnose, predict, and ultimately prevent SCA and SCD in the young.

对于临床医生、研究人员、患者及其家属来说,青少年不明原因的心脏骤停(SCA)和心脏性猝死(SCD)仍然是一个至关重要的问题。在这篇综述中,我们将探讨青少年 SCA 和 SCD 评估的现状,包括最近发现的单基因和多基因疾病、心脏成像技术的进步以及我们对普肯野系统在引发危及生命甚至致命的室性心律失常中的作用的日益深入的了解。然而,尽管取得了这些进步,在心脏结构看似正常的人中,仍有超过三分之一的 SCA 和 SCD 原因不明。我们探讨了人工智能、新型生物标记物、多模态心脏成像、基因发现以及可穿戴设备和传感器在缩小当前差距方面的未来作用。在本综述提供的总体框架下,我们展望未来,患者、临床医生、研究人员、创新者和政策制定者将通力合作,最终使我们有能力诊断、预测并最终预防年轻人的 SCA 和 SCD。
{"title":"Unexplained Sudden Cardiac Arrest and Sudden Cardiac Death in the Young: What is Killing These Young People When Nothing is Found?","authors":"Andrew S Tseng, Mayank Sardana, John R Giudicessi, Michael J Ackerman","doi":"10.1016/j.tcm.2024.11.002","DOIUrl":"https://doi.org/10.1016/j.tcm.2024.11.002","url":null,"abstract":"<p><p>Unexplained sudden cardiac arrest (SCA) and sudden cardiac death (SCD) in the young remains a critical issue for clinicians, researchers, patients and their family members. In this review, we explore the current status of SCA and SCD evaluation in the young, including recent monogenic and polygenic disease discoveries, advancements in cardiac imaging and our growing understanding of the role of the Purkinje system in triggering life threatening and even fatal ventricular arrhythmias. Yet, despite these advancements, over a third of SCA and SCD among individuals with seemingly structurally normal hearts remain unexplained. We explore the future role of artificial intelligence, novel biomarkers, multimodality cardiac imaging, genetic discoveries, as well as wearable devices and sensors in closing this current gap. With the overarching framework provided in this review, we envision a future in which collaboration among patients, clinicians, researchers, innovators, and policy makers culminates in our ability to diagnose, predict, and ultimately prevent SCA and SCD in the young.</p>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial commentary: Polygenic risk and coronary artery calcium score: Joining forces in preventive cardiology. 编辑评论:多基因风险与冠状动脉钙化评分:预防性心脏病学中的强强联手。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-09 DOI: 10.1016/j.tcm.2024.11.001
Alexandros Kasiakogias, Costas Tsioufis, George Lazaros
{"title":"Editorial commentary: Polygenic risk and coronary artery calcium score: Joining forces in preventive cardiology.","authors":"Alexandros Kasiakogias, Costas Tsioufis, George Lazaros","doi":"10.1016/j.tcm.2024.11.001","DOIUrl":"10.1016/j.tcm.2024.11.001","url":null,"abstract":"","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142631902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applying guidelines directed medical therapy for heart failure: The cardiologist hard job. 应用指南指导心力衰竭的药物治疗:心脏病医生的艰巨任务
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-05 DOI: 10.1016/j.tcm.2024.10.004
Gabriele Fragasso
{"title":"Applying guidelines directed medical therapy for heart failure: The cardiologist hard job.","authors":"Gabriele Fragasso","doi":"10.1016/j.tcm.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.tcm.2024.10.004","url":null,"abstract":"","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":" ","pages":""},"PeriodicalIF":7.3,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial commentary: Exercise and the risk of atrial fibrillation at both ends of the pathological and physiological hypertrophy spectrum 运动与病理性和生理性肥胖两端的心房颤动风险。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.01.008
Brad Dieter
{"title":"Editorial commentary: Exercise and the risk of atrial fibrillation at both ends of the pathological and physiological hypertrophy spectrum","authors":"Brad Dieter","doi":"10.1016/j.tcm.2024.01.008","DOIUrl":"10.1016/j.tcm.2024.01.008","url":null,"abstract":"","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 516-517"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139713326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leadless pacemakers: Where are we? 无铅起搏器:我们在哪里?
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.03.001
Nicholas Beccarino, Moussa Saleh, Laurence M. Epstein
Pacemakers have been the cornerstone of brady-arrhythmia management since the mid-20th century. Despite the widespread use and success of traditional transvenous pacemakers, they are associated with an estimated 15 % complication rate at three years. Driven by the advantages over traditional transvenous pacemakers including a lack of transvenous leads, resistance to infection, and ease of implantation, the number of leadless pacemakers placed annually in the United States has dramatically increased since their initial approval. While current iterations of leadless pacemakers lack the versatility offered by transvenous devices, recent advances in leadless pacing offer an increasingly diverse range of therapeutic options. This review will discuss the past, present, and future emerging technologies, and strategies in leadless pacing
自 20 世纪中叶以来,起搏器一直是治疗缓慢性心律失常的基石。尽管传统的经静脉起搏器得到了广泛应用并取得了巨大成功,但其三年的并发症发生率估计为 15%。与传统的经静脉起搏器相比,无导联起搏器具有不需要经静脉导线、抗感染和易于植入等优点,因此自最初获得批准以来,美国每年植入的无导联起搏器数量急剧增加。虽然目前迭代的无导联起搏器缺乏经静脉设备所提供的多功能性,但无导联起搏的最新进展提供了越来越多样化的治疗选择。本综述将讨论无导线起搏领域过去、现在和未来的新兴技术和策略。
{"title":"Leadless pacemakers: Where are we?","authors":"Nicholas Beccarino,&nbsp;Moussa Saleh,&nbsp;Laurence M. Epstein","doi":"10.1016/j.tcm.2024.03.001","DOIUrl":"10.1016/j.tcm.2024.03.001","url":null,"abstract":"<div><div>Pacemakers have been the cornerstone of brady-arrhythmia management since the mid-20th century. Despite the widespread use and success of traditional transvenous pacemakers, they are associated with an estimated 15 % complication rate at three years. Driven by the advantages over traditional transvenous pacemakers including a lack of transvenous leads, resistance to infection, and ease of implantation, the number of leadless pacemakers placed annually in the United States has dramatically increased since their initial approval. While current iterations of leadless pacemakers lack the versatility offered by transvenous devices, recent advances in leadless pacing offer an increasingly diverse range of therapeutic options. This review will discuss the past, present, and future emerging technologies, and strategies in leadless pacing</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 531-538"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140208177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial commentary: Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care 肾脏心脏病学的兴起:综合管理心血管疾病和肾脏疾病,为患者提供全面护理。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.04.002
Mikhail S. Dzeshka , Alena Shantsila , Gregory Y.H. Lip , Eduard Shantsila
{"title":"Editorial commentary: Emergence of nephrocardiology: Integrating management of cardiovascular and kidney diseases for holistic patient care","authors":"Mikhail S. Dzeshka ,&nbsp;Alena Shantsila ,&nbsp;Gregory Y.H. Lip ,&nbsp;Eduard Shantsila","doi":"10.1016/j.tcm.2024.04.002","DOIUrl":"10.1016/j.tcm.2024.04.002","url":null,"abstract":"","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 549-551"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140759877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action 超越肥胖和 2 型糖尿病的 GLP-1 受体激动剂对心血管的影响:抗动脉粥样硬化作用。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.03.003
Kleopatra Alexiadou , Adam Hartley , Tricia M-M Tan , Ramzi Khamis
Obesity and overweight affect almost one third of the European population. Obesity and its associated conditions, including type 2 diabetes, significantly impact healthcare systems, life expectancy and quality of life. The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of obesity, with or without diabetes, has provided an effective alternative to metabolic surgery and dietary interventions. We are now beginning to understand their pleiotropic effects beyond weight loss, such as their favourable impact on cardiovascular profiles. The aim of this review is to summarize available preclinical and clinical data on the beneficial effects of GLP-1 receptor agonists on atherosclerosis and cardiovascular disease which has the potential to substantially broaden the scope of their clinical applications.
肥胖和超重影响着近三分之一的欧洲人口。肥胖症及其相关疾病,包括 2 型糖尿病,对医疗保健系统、预期寿命和生活质量产生了重大影响。胰高血糖素样肽-1(GLP-1)受体激动剂的出现为治疗肥胖症(伴有或不伴有糖尿病)提供了新陈代谢手术和饮食干预的有效替代方案。我们现在开始了解它们在减轻体重之外的多重效应,例如对心血管的有利影响。本综述旨在总结 GLP-1 受体激动剂对动脉粥样硬化和心血管疾病有益影响的现有临床前和临床数据,这些数据有可能大大拓宽 GLP-1 受体激动剂的临床应用范围。
{"title":"The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action","authors":"Kleopatra Alexiadou ,&nbsp;Adam Hartley ,&nbsp;Tricia M-M Tan ,&nbsp;Ramzi Khamis","doi":"10.1016/j.tcm.2024.03.003","DOIUrl":"10.1016/j.tcm.2024.03.003","url":null,"abstract":"<div><div>Obesity and overweight affect almost one third of the European population. Obesity and its associated conditions, including type 2 diabetes, significantly impact healthcare systems, life expectancy and quality of life. The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of obesity, with or without diabetes, has provided an effective alternative to metabolic surgery and dietary interventions. We are now beginning to understand their pleiotropic effects beyond weight loss, such as their favourable impact on cardiovascular profiles. The aim of this review is to summarize available preclinical and clinical data on the beneficial effects of GLP-1 receptor agonists on atherosclerosis and cardiovascular disease which has the potential to substantially broaden the scope of their clinical applications.</div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 552-557"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140330311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial commentary: Leadless pacemaker: The revolution is underway 无引线起搏器:革命正在进行。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.03.006
Antoine Da Costa, Karim Benali
{"title":"Editorial commentary: Leadless pacemaker: The revolution is underway","authors":"Antoine Da Costa,&nbsp;Karim Benali","doi":"10.1016/j.tcm.2024.03.006","DOIUrl":"10.1016/j.tcm.2024.03.006","url":null,"abstract":"","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 539-540"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140330310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From cardiorenal syndrome to nephrocardiology: The journey of exploring the interconnection between nephrology and cardiovascular medicine 从心肾综合征到肾脏心脏病学:探索肾脏病学和心血管医学之间相互联系的历程。
IF 7.3 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-11-01 DOI: 10.1016/j.tcm.2024.03.002
Parta Hatamizadeh
The knowledge about the pathophysiology of cardiorenal syndrome has evolved remarkably over the past two decades. However, cardiorenal syndrome is only one subject within a much broader field of nephrocardiology, which encompasses the interconnection between nephrology and cardiovascular medicine from nine different standpoints of pathophysiology, epidemiology, prevention, prognosis, diagnosis, therapy, monitoring, risk factors and systemic diseases. The complexities of these nine elements of the interaction between nephrology and cardiovascular medicine are not adequately addressed in either of those two fields of medicine. Nephrocardiology is an emerging field in medicine aiming at addressing those subtleties to improve prognosis and quality of life of a large and vulnerable patient population with combined cardiovascular and nephrology related conditions.
在过去二十年里,有关心肾综合征病理生理学的知识有了长足的发展。然而,心肾综合征只是肾脏心脏病学这一更为广阔领域中的一个课题,肾脏心脏病学从病理生理学、流行病学、预防、预后、诊断、治疗、监测、危险因素和系统疾病等九个不同方面涵盖了肾脏病学和心血管医学之间的相互联系。肾脏内科和心血管内科之间相互作用的这九个方面的复杂性在这两个医学领域中的任何一个领域都没有得到充分解决。肾脏心脏病学是一个新兴的医学领域,旨在解决这些微妙的问题,以改善大量合并心血管和肾脏病相关疾病的脆弱患者的预后和生活质量。
{"title":"From cardiorenal syndrome to nephrocardiology: The journey of exploring the interconnection between nephrology and cardiovascular medicine","authors":"Parta Hatamizadeh","doi":"10.1016/j.tcm.2024.03.002","DOIUrl":"10.1016/j.tcm.2024.03.002","url":null,"abstract":"<div><div><span><span>The knowledge about the pathophysiology of </span>cardiorenal syndrome has evolved remarkably over the past two decades. However, cardiorenal syndrome is only one subject within a much broader field of nephrocardiology, which encompasses the interconnection between </span>nephrology<span><span> and cardiovascular medicine<span> from nine different standpoints of pathophysiology, epidemiology, prevention, prognosis, diagnosis, therapy, monitoring, risk factors and </span></span>systemic diseases<span>. The complexities of these nine elements of the interaction between nephrology and cardiovascular medicine are not adequately addressed in either of those two fields of medicine. Nephrocardiology is an emerging field in medicine aiming at addressing those subtleties to improve prognosis and quality of life of a large and vulnerable patient population with combined cardiovascular and nephrology related conditions.</span></span></div></div>","PeriodicalId":51199,"journal":{"name":"Trends in Cardiovascular Medicine","volume":"34 8","pages":"Pages 541-546"},"PeriodicalIF":7.3,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140195035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Trends in Cardiovascular Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1